scispace - formally typeset
E

Elena Ladich

Researcher at Johnson & Johnson

Publications -  115
Citations -  11054

Elena Ladich is an academic researcher from Johnson & Johnson. The author has contributed to research in topics: Stent & Drug-eluting stent. The author has an hindex of 39, co-authored 112 publications receiving 10096 citations.

Papers
More filters
Journal ArticleDOI

Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk

TL;DR: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration, and the cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
Journal ArticleDOI

The Pathology of Neoatherosclerosis in Human Coronary Implants: Bare-Metal and Drug-Eluting Stents

TL;DR: Neoatherosclerosis is a frequent finding in DES and occurs earlier than in BMS, and may be yet another rare contributing factor to late thrombotic events.
Journal ArticleDOI

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients An Autopsy Study

TL;DR: Vessel healing at the culprit site in AMI patients treated with DES is substantially delayed compared with the culprit sites in patients receiving DES for stable angina, emphasizing the importance of underlying plaque morphology in the arterial response to DES.
Journal ArticleDOI

Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis

TL;DR: Compared with other causes of myocardial infarction, eosinophilic infiltrates are more common in thrombi harvested from very late DES thrombosis, particularly in sirolimus-eluting stents, and correlate with the extent of stent malapposition.
Journal ArticleDOI

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

TL;DR: CoCr-EES demonstrated greater strut coverage with less inflammation, less fibrin deposition, and less late and very late stent thrombosis compared with SES and PES in human autopsy analysis, indicating that careful long-term follow-up remains important even after CoCr- EES placement.